ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Perindopril Amlodipin Indapamid Spirig HC 10 mg/5 mg/2,5 mg, Filmtabletten - 30
69202005 Spirig HealthCare AG
Perindopril Amlodipin Indapamid Spirig HC 10 mg/5 mg/2,5 mg, Filmtabletten20.12.2023
Generic20.12.2023
Perindopril, Amlodipine and Indapamide (C09BX01) 
WHO-DDD19.12.2028
02.07.20.30
02.07.20. 
B  
Yes 
IP 
15.22Yes
    
10 %33.05
  
7680692020055Synthetika
  
Composition
Filmtablette: perindoprilum argininum 10 mg corresp. perindoprilum 6.79 mg amlodipinum 5 mg ut amlodipini besilas 6.935 mg, indapamidum 2.5 mg, cellulosum microcristallinum, calcii carbonas, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 1.19 mg, magnesii stearas, silica colloidalis anhydrica, Überzug: copolymerum macrogolo et alcoholi poly(vinylico) constatum, talcum, glyceroli monocaprylocapras, poly(alcohol vinylicus), E 171, E 172 (flavum), E 172 (nigrum), E 172 (rubrum), pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDoseadditional_information
Amlodipine5 mg 
Indapamide2.5 mg 
Perindopril Arginine10 mg correspond Perindopril 6.79 mgFilmtablette
BAG: Active AgentDose
Amlodipine5 mg
Indapamide2.5 mg
Perindopril Arginine10 mg
 
Inactive agents additional_information
(Flavum)  
(Nigrum)  
(Rubrum)  
Amylum Pregelificatum  
Calcium Carbonate  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
Copolymerum Macrogolo et Alcoholi Poly(Vinylico) Constatum Überzug
E 171 color.
E 172 color.
Glyceroli Monocaprylocapras  
Magnesii Stearas  
Poly(Alcohol Vinylicus)  
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 05.01.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home